Envestnet Asset Management Inc Sorrento Therapeutics, Inc. Transaction History

Envestnet Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$0.74 - $1.83 $8,785 - $21,725	11,872 New	11,872 $10,000
Q1 2020 Apr 23, 2020	SELL	$1.57 - $4.76 $28,043 - $85,023	-17,862 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$1.45 - $4.17 $2,649 - $7,618	1,827 Added 11.39%	17,862 $60,000
Q3 2019 Oct 17, 2019	SELL	$2.05 - $2.69 $2,878 - $3,776	-1,404 Reduced 8.05%	16,035 $34,000
Q2 2019 Aug 02, 2019	BUY	$2.67 - $4.38 $6,741 - $11,059	2,525 Added 16.93%	17,439 $47,000
Q1 2019 May 10, 2019	BUY	$1.86 - $5.94 $8,027 - $25,637	4,316 Added 40.72%	14,914 $71,000
Q4 2018 Feb 13, 2019	BUY	$2.01 - $4.24 $21,301 - $44,935	10,598 New	10,598 $25,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.